spacer
spacer

PDBsum entry 3ccc

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Hydrolase PDB id
3ccc

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
724 a.a. *
Ligands
NAG-NAG ×4
NAG ×12
7AC ×4
Waters ×277
* Residue conservation analysis
PDB id:
3ccc
Name: Hydrolase
Title: Crystal structure of human dpp4 in complex with a benzimidazole derivative
Structure: Dipeptidyl peptidase 4. Chain: a, b, c, d. Synonym: dipeptidyl peptidase iv, dpp iv, t-cell activation antigen cd26, tp103, adenosine deaminase complexing protein 2, adabp. Engineered: yes
Source: Homo sapiens. Human. Gene: dpp4, adcp2, cd26. Expressed in: spodoptera frugiperda. Expression_system_cell_line: sf9.
Resolution:
2.71Å     R-factor:   0.204     R-free:   0.267
Authors: M.B.Wallace,R.J.Skene
Key ref: M.B.Wallace et al. (2008). Structure-based design and synthesis of benzimidazole derivatives as dipeptidyl peptidase IV inhibitors. Bioorg Med Chem Lett, 18, 2362-2367. PubMed id: 18346892
Date:
25-Feb-08     Release date:   21-Oct-08    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P27487  (DPP4_HUMAN) -  Dipeptidyl peptidase 4 from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
766 a.a.
724 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.3.4.14.5  - dipeptidyl-peptidase Iv.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Release of an N-terminal dipeptide, Xaa-Xbb-|-Xcc, from a polypeptide, preferentially when Xbb is Pro, provided Xcc is neither Pro nor hydroxyproline.

 

 
Bioorg Med Chem Lett 18:2362-2367 (2008)
PubMed id: 18346892  
 
 
Structure-based design and synthesis of benzimidazole derivatives as dipeptidyl peptidase IV inhibitors.
M.B.Wallace, J.Feng, Z.Zhang, R.J.Skene, L.Shi, C.L.Caster, D.B.Kassel, R.Xu, S.L.Gwaltney.
 
  ABSTRACT  
 
A novel series of non-covalent, benzimidazole-based inhibitors of DPP-4 has been developed from a small fragment hit using structure-based drug design. A highly versatile synthetic route was created for the development of SAR, which led to the discovery of potent and selective inhibitors with excellent pharmaceutical properties.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
20471246 C.W.Murray, and T.L.Blundell (2010).
Structural biology in fragment-based drug design.
  Curr Opin Struct Biol, 20, 497-507.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.

 

spacer

spacer